24 May 2013
Keywords: phase, ii, results, lilly, olanzapine, eli, new
Article | 18 July 1994
Eli Lilly's new atypical antipsychotic agent olanzapine may prove to
have efficacy in treating both the positive and negative symptoms ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
18 July 1994
25 July 1994
23 May 2013
© 2013 thepharmaletter.com